{"name":"Radiation Therapy Oncology Group","slug":"radiation-therapy-oncology-group","ticker":"","exchange":"","domain":"rtog.org","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":7,"colorKey":"cardiovascular","drugs":[{"name":"Anti-androgen","genericName":"Anti-androgen","slug":"anti-androgen","indication":"Other","status":"phase_3"},{"name":"Biafine cream","genericName":"Biafine cream","slug":"biafine-cream","indication":"Other","status":"marketed"},{"name":"Consolidation Paclitaxel","genericName":"Consolidation Paclitaxel","slug":"consolidation-paclitaxel","indication":"Other","status":"phase_2"},{"name":"Eulexin","genericName":"Eulexin","slug":"eulexin","indication":"Other","status":"marketed"},{"name":"LHRH","genericName":"LHRH","slug":"lhrh","indication":"Other","status":"marketed"},{"name":"concurrent temozolomide","genericName":"concurrent temozolomide","slug":"concurrent-temozolomide","indication":"Glioblastoma multiforme","status":"phase_3"},{"name":"radioprotection","genericName":"radioprotection","slug":"radioprotection","indication":"Other","status":"phase_1"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"immunology","drugs":[{"name":"AA","genericName":"AA","slug":"aa","indication":"Cancer treatment","status":"marketed"},{"name":"CCNU","genericName":"CCNU","slug":"ccnu","indication":"Brain tumors (glioblastoma, high-grade gliomas)","status":"phase_3"},{"name":"Consolidation Carboplatin","genericName":"Consolidation Carboplatin","slug":"consolidation-carboplatin","indication":"Ovarian cancer","status":"phase_2"},{"name":"Induction Paclitaxel","genericName":"Induction Paclitaxel","slug":"induction-paclitaxel","indication":"Breast cancer","status":"phase_2"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Sm-153","genericName":"Sm-153","slug":"sm-153","indication":"Pain relief in bone metastases","status":"phase_3"}]}],"pipeline":[{"name":"Sm-153","genericName":"Sm-153","slug":"sm-153","phase":"phase_3","mechanism":"Sm-153 is a radioactive isotope used for targeted radiation therapy.","indications":["Pain relief in bone metastases"],"catalyst":""},{"name":"AA","genericName":"AA","slug":"aa","phase":"marketed","mechanism":"Radiation therapy is a treatment that uses high doses of radiation to kill cancer cells.","indications":["Cancer treatment"],"catalyst":""},{"name":"Anti-androgen","genericName":"Anti-androgen","slug":"anti-androgen","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Biafine cream","genericName":"Biafine cream","slug":"biafine-cream","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"CCNU","genericName":"CCNU","slug":"ccnu","phase":"phase_3","mechanism":"CCNU (lomustine) is a nitrosourea alkylating agent that cross-links DNA strands, preventing cell replication and inducing cancer cell death.","indications":["Brain tumors (glioblastoma, high-grade gliomas)","Hodgkin lymphoma","Non-Hodgkin lymphoma","Melanoma"],"catalyst":""},{"name":"Consolidation Carboplatin","genericName":"Consolidation Carboplatin","slug":"consolidation-carboplatin","phase":"phase_2","mechanism":"Carboplatin works by interfering with DNA replication in cancer cells, leading to cell death.","indications":["Ovarian cancer","Non-small cell lung cancer","Breast cancer","Testicular cancer"],"catalyst":""},{"name":"Consolidation Paclitaxel","genericName":"Consolidation Paclitaxel","slug":"consolidation-paclitaxel","phase":"phase_2","mechanism":"Paclitaxel works by inhibiting cell division, thereby preventing cancer cells from multiplying.","indications":[],"catalyst":""},{"name":"Eulexin","genericName":"Eulexin","slug":"eulexin","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Induction Paclitaxel","genericName":"Induction Paclitaxel","slug":"induction-paclitaxel","phase":"phase_2","mechanism":"Inhibits microtubule assembly by binding to tubulin","indications":["Breast cancer","Ovarian cancer","Lung cancer"],"catalyst":""},{"name":"LHRH","genericName":"LHRH","slug":"lhrh","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"concurrent temozolomide","genericName":"concurrent temozolomide","slug":"concurrent-temozolomide","phase":"phase_3","mechanism":"Temozolomide is an alkylating agent that works by interfering with DNA replication in cancer cells.","indications":["Glioblastoma multiforme","Anaplastic astrocytoma"],"catalyst":""},{"name":"radioprotection","genericName":"radioprotection","slug":"radioprotection","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2025-12-03","type":"trial","source":"businesswire.com","summary":"Lantern Pharma Reports Additional Positive LP-184 Phase 1a Results Showing Durable Disease Control in Heavily Pre-Treated Advanced Cancer Patients as Company Advances Precision Oncology Program into M","headline":"Lantern Pharma Reports Additional Positive LP-184 Phase 1a Results Showing Durable Disease Control in Heavily Pre-Treate","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPMy14aFJ3alcwaEcwN19hazdGWWZZQ1N6R0VvSlE4a3Y4YUV5R3Q5NlRaUEVCd1c2MXlpSlpUdFlHazJMdWhNSGJRdk5oN3FRV0tPLVJONThZZ0VTcHR4MVRzZHlpT2h6Z0lPaV9HV2x1RXUzQVE2MXE0TUpXa1ExcjIxNDYzU1dsS2VPWmhrV2Y4dUZlNzlUUFlLRTFJcHNyUVlNZEJub1g?oc=5","date":"2025-10-06","type":"pipeline","source":"Technology Magazine","summary":"Technology at the Heart of Servier’s Patient-First Approach - Technology Magazine","headline":"Technology at the Heart of Servier’s Patient-First Approach","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOTzdCQ254SVJEMzJGejk5YjBkd2hPOGRRcUFNcUlGdzFxcWYzV2NxSXFVYTVRckdGREQ0d1hBUnJ5LVpYOW9ta0RYNFE5dmdpU2VjaWhzRWtxU3lIQmlNdHJJbHZ0RWpJQWpqdlI1X29uN2FibEhEY0dfTUc2RERnRmVRbXpOY2VIdThRaENwdEFUWXU4OGJiVlREZTBTbnBsZmJNWU9IcE5ISXpzNElv?oc=5","date":"2025-10-02","type":"pipeline","source":"Science | AAAS","summary":"New radioactive isotope therapies promise more targeted attacks on cancer - Science | AAAS","headline":"New radioactive isotope therapies promise more targeted attacks on cancer - Science | AAAS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQRlRtMVp6VUNweXJtTWwwbjRlTmV5bzVnWWY0d3ByV0F2VUwwR1l6c2dXUWdUOFFoeEstVDJEOTRvVjlVaGpEdHhFM0czWWxxLVZUVGxTNUNDeEtsYTlDTklfS3JDdDVKYVFxZllyRVR1M01Vbm1vdXlXdm56TGR6dHVqQmtqTG9iSjBJbUp4QlNUM29Oa1FFbUR0Z3pXWmZpODlqN3Rn?oc=5","date":"2025-09-30","type":"pipeline","source":"McMaster News","summary":"Mac launches pharmaceutical company to seek out and destroy cancerous tumours - McMaster News","headline":"Mac launches pharmaceutical company to seek out and destroy cancerous tumours","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQYkJzbE1HalpDVHJoMmIzbkNVMG9ISWstT3QwanZYbGV3WG5sVnZ3YVlybVAxTmtCTUw5aWViWkNLRTcwZFVuS0w2dVBXUWZUSzdGN1Z4a3VNbTR1T2tnVWZfREttVG1lQXRqLURlQ1ZXQXBZMHJJaDk1RUtTZDE2ak9BOERZblFpX0k1TVJld25pWTExSmo5YWlBUTdHdkdjajJIN19RM2Vac3NmakRF?oc=5","date":"2025-08-06","type":"regulatory","source":"Fierce Pharma","summary":"Jazz's Modeyso becomes first FDA-approved drug for type of aggressive brain cancer - Fierce Pharma","headline":"Jazz's Modeyso becomes first FDA-approved drug for type of aggressive brain cancer","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE1CLVZncG5SbXY5c0JqWG9sYlRqdVpoVVEyeGFjYi1ZaUVPbk1yN3N3a0l5bHlGRVZUdW05Ymp2cVlqeFI4bTlPcDhxanIxYnZvRjE1X3hHNGl3NnNSdzl4Q291YXUwNUxPZHNLeWJRNjd6emRs?oc=5","date":"2025-07-25","type":"pipeline","source":"sumitomocorp.com","summary":"Sumitomo Corporation Invests in AI-based Cancer Radiation Therapy Startup AiRato and Signs Exclusive Overseas Distribution Agreement - sumitomocorp.com","headline":"Sumitomo Corporation Invests in AI-based Cancer Radiation Therapy Startup AiRato and Signs Exclusive Overseas Distributi","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-07","type":"trial","source":"prnewswire.com","summary":"Lutris Pharma Presents Additional Positive Data from Its Phase 2 Trial of LUT014 Gel Demonstrating Significant Efficacy in Treating Acneiform Rash Associated with Use of Anti-EGFR Cancer Therapies at ","headline":"Lutris Pharma Presents Additional Positive Data from Its Phase 2 Trial of LUT014 Gel Demonstrating Significant Efficacy ","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNenBULVdHT2EwU0lOUmpORmJpN0NrT0ZwOHVkOXdMT2t3QlN6UkZJVmpwZ1RQLU5BSXpxVElRd3FLUGNpOXRzOUhQRWxzNjF6SzJJeGVjVXRidlJnV2t2R3pFRk5wRlBlVm9FRlo2WEFyYkU1NTAzT1lTZkNERklIbm1oZU82Y2ZUblg2NlN2ZzNjQjdVM2xPdGJ0LWNiQW1NdjZwY2g3UVRiZE45TDIw?oc=5","date":"2025-06-11","type":"deal","source":"Fierce Biotech","summary":"BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal - Fierce Biotech","headline":"BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNT1gxMnRDenpnb3R6eXgtUnhKdnR6Q0Q2U1VuTUZzajBvSWJCbnZjT1piSW9NS0R4QkhzZTVxcGtISGlFaXJyNVdEQ2VUa2RLSDJoaVhmREZHeHE2dVB2TkZiZW1HUUF6MHkzZUlYSnlrQ2RMTnFwb2RDaEw3bEVQVWdpX2RrUk9HSWFsdDFtb3R3ZkI0ZlFudEVvVW9FWmY4bHR6ZW5jcU9oaHFWZ25EaHpn?oc=5","date":"2025-05-12","type":"pipeline","source":"BioSpace","summary":"Radiopharma Powerhouses Push Frontiers With New Indications, Innovation - BioSpace","headline":"Radiopharma Powerhouses Push Frontiers With New Indications, Innovation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxOZVdad0dfMUlzNndhWkNoLUpXQ0UtY1dHWG5jN1VfUzhKaktpMHB6b0YwX2tZMjltTE53dl94dUNjVGZaNW5LUEJ2NkNVWlN5UWZ3MkpDN0R6d0ZPNmswb1VRN21DWUxkRXQyLWNiazNhdk5OY0U4UDBza1lFcm9OSGx4YWd1Nmc?oc=5","date":"2025-04-27","type":"pipeline","source":"The New York Times","summary":"Medicine Spares Cancer Patients From Grisly Surgeries and Harsh Therapies - The New York Times","headline":"Medicine Spares Cancer Patients From Grisly Surgeries and Harsh Therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE9wN0xsQ0dJbl96UTkzc0FfazhXRkRlLUNyNkdtWkM1RF85eWZLYWZkUWVwdUVSdzZ2a25TTXJSZXFpRE1oMUxBNHcxUXhmSEtyaUMzeVVQdEQ5eHhBemtLc0loNEc2bHJqOEE?oc=5","date":"2023-12-13","type":"pipeline","source":"Wiley Online Library","summary":"Pharmaceutical management of acute radiation dermatitis in the German speaking radiation oncology community - Wiley Online Library","headline":"Pharmaceutical management of acute radiation dermatitis in the German speaking radiation oncology community","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNNktMb05RcWVoSllEZG5iLUtuRVhocnVfbG12OV9yYVdfekpzSDg4Z2ZUQTlabVRSNlFqYjk0ZnhQSVZhTTBWRDUzTVIxRnNjeE1RdXY4czdxWmZYUUZFa3lTWmxaR18zVHRYSzc5a3EyRUlYNUNnaHJXUDl0eVFUb0RuY2h6ajFJZ1ZHRUpDVXFDallrWnUyRE9HSk9GZmhrdkliQ2RIUjd6OUpGSmpaNVE1LURmY2xWSlE?oc=5","date":"2023-03-14","type":"pipeline","source":"Pharmaceutical Technology","summary":"Who are the leading innovators in cancer radiotherapy for the pharmaceutical industry? - Pharmaceutical Technology","headline":"Who are the leading innovators in cancer radiotherapy for the pharmaceutical industry?","sentiment":"neutral"}],"patents":[],"drugCount":12,"phaseCounts":{"phase_3":4,"marketed":4,"phase_2":3,"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}